BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 19144878)

  • 41. Angiogenesis: bench to bedside, have we learned anything?
    Lee SU; Wykrzykowska JJ; Laham RJ
    Toxicol Pathol; 2006; 34(1):3-10. PubMed ID: 16507538
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of cerebral arteriogenesis leads to early-phase expression of protease inhibitors in growing collaterals of the brain.
    Hillmeister P; Lehmann KE; Bondke A; Witt H; Duelsner A; Gruber C; Busch HJ; Jankowski J; Ruiz-Noppinger P; Hossmann KA; Buschmann IR
    J Cereb Blood Flow Metab; 2008 Nov; 28(11):1811-23. PubMed ID: 18594555
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cellular and pharmacological targets to induce coronary arteriogenesis.
    Hollander MR; Horrevoets AJ; van Royen N
    Curr Cardiol Rev; 2014 Feb; 10(1):29-37. PubMed ID: 23638831
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapeutic manipulation of the collateral circulation--future directions.
    van Royen N; Piek JJ
    Coron Artery Dis; 2004 Nov; 15(7):399-403. PubMed ID: 15492588
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Collateral growth in the peripheral circulation: a review.
    Unthank JL; Sheridan KM; Dalsing MC
    Vasc Endovascular Surg; 2004; 38(4):291-313. PubMed ID: 15306947
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic angiogenesis: a new treatment approach for ischemic heart disease--part I.
    Ahn A; Frishman WH; Gutwein A; Passeri J; Nelson M
    Cardiol Rev; 2008; 16(4):163-71. PubMed ID: 18562806
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic angiogenesis: a new treatment approach for ischemic heart disease--Part II.
    Ahn A; Frishman WH; Gutwein A; Passeri J; Nelson M
    Cardiol Rev; 2008; 16(5):219-29. PubMed ID: 18708823
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Angiogenesis achieved by granulocyte colony-stimulating factor in combination with bypass surgery in 2 cases of critical limb ischemia.
    Nakayama M; Asari Y
    Circ J; 2008 Aug; 72(8):1385-7. PubMed ID: 18654031
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changing the logic of therapeutic angiogenesis for ischemic disease.
    Emanueli C; Madeddu P
    Trends Mol Med; 2005 May; 11(5):207-16. PubMed ID: 15882608
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic approaches in the stimulation of the coronary collateral circulation.
    Degen A; Millenaar D; Schirmer SH
    Curr Cardiol Rev; 2014 Feb; 10(1):65-72. PubMed ID: 23721076
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Experimental models of arteriogenesis: differences and implications.
    Hoefer IE; van Royen N; Jost MM
    Lab Anim (NY); 2006 Feb; 35(2):36-44. PubMed ID: 16446736
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Growing around blocked arteries.
    Harv Heart Lett; 2002 Feb; 12(6):4-5. PubMed ID: 11869967
    [No Abstract]   [Full Text] [Related]  

  • 53. Anatomic considerations in therapeutic arteriogenesis for cerebral ischemia.
    Liebeskind DS
    Circulation; 2004 Jan; 109(2):e4; author reply e4. PubMed ID: 14734507
    [No Abstract]   [Full Text] [Related]  

  • 54. Fibroblast growth factor 4 gene therapy for chronic ischemic heart disease.
    Kapur NK; Rade JJ
    Trends Cardiovasc Med; 2008 May; 18(4):133-41. PubMed ID: 18555186
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PPARγ activation inhibits cerebral arteriogenesis in the hypoperfused rat brain.
    Duelsner A; Gatzke N; Hillmeister P; Glaser J; Zietzer A; Nagorka S; Janke D; Pfitzner J; Stawowy P; Meyborg H; Urban D; Bondke Persson A; Buschmann IR
    Acta Physiol (Oxf); 2014 Feb; 210(2):354-68. PubMed ID: 24119262
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention of tissue death by killer cells? The role of the immune system in arteriogenesis.
    Schaper W
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2273-4. PubMed ID: 17761935
    [No Abstract]   [Full Text] [Related]  

  • 57. Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms.
    Lähteenvuo JE; Lähteenvuo MT; Kivelä A; Rosenlew C; Falkevall A; Klar J; Heikura T; Rissanen TT; Vähäkangas E; Korpisalo P; Enholm B; Carmeliet P; Alitalo K; Eriksson U; Ylä-Herttuala S
    Circulation; 2009 Feb; 119(6):845-56. PubMed ID: 19188502
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combating cardiovascular disease with angiogenic therapy.
    Jacobs J
    Drug Discov Today; 2007 Dec; 12(23-24):1040-5. PubMed ID: 18061883
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Arteriogenesis - is this terminology necessary?
    Buschmann I; Katzer E; Bode C
    Basic Res Cardiol; 2003 Feb; 98(1):1-5. PubMed ID: 12494262
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of image-guided vascular intervention in therapeutic angiogenesis translational research.
    Hwang GL; Patel TH; Hofmann LV
    Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):903-15. PubMed ID: 17867920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.